Th17 cells and interleukin-17 (IL-17) have been found to play an important role in the pathology of multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Response to IL-17, reactive astrocytes accompany with immune cells infiltration and axonal damage in MS/EAE. However, the role and the regulatory mechanism of IL-17-activated astrocytes in inflammation and in the EAE process still remain largely unknown.
glia and neurons have been shown to respond to IL-17 via IL-17 receptor (Gaffen, 2011; Waisman et al., 2015) . IL-17 activates and enhances the release of chemokine and pro-inflammatory cytokines in astrocytes, which promotes the migration of CCR6 + Th17 cells to the site of inflammation Meares, Ma, Qin, & Benveniste, 2012) . Moreover, the presence of reactive astrocytes and axonal damage is an early event during multiple sclerosis lesion formation and lead to astrocyte immune responses (Brosnan & Raine, 2013; Ponath et al., 2017) . These discoveries provide important insights into the astrocytes and Th17/IL-17 that regulate inflammation and MS progression. However, the entirety of regulatory network has not been fully described.
Suppressor of cytokine signaling protein (SOCS) belongs to one of the intracellular cytokine inducible protein family, and controls inflammatory and immune responses (Cianciulli, Calvello, Porro, Trotta, & Panaro, 2017) . SOCS3, a member of the SOCS family, is a negative modulator of the Janus kinase/signal transducer and activator of transcription 3 (JAK/STAT3) pathways and a feedback inhibitor that down-regulates cytokine receptor signaling (Noh, Jung, Cha, Han, & Park, 2017) . Furthermore, SOCS3 is involved in the progression of MS. It has been shown that CD4 + T cells, CD8 + T cells and monocytes from relapsing-remitting MS patients express less SOCS3 and more phosphorylation of STAT3 (p-STAT3) during relapse than that during remission (Jakkula et al., 2010) . Importantly, SOCS3 is associated with reactive astrocytes in models of acute injury (Ben Haim et al., 2015) .
The production of chemokines in activated astrocytes is inhibited by SOCS3, which limits inflammatory and immune responses within the CNS (Qin, Niyongere, Lee, Baker, & Benveniste, 2008) .
MicroRNAs (miRNAs), a class of small noncoding RNAs, regulate negatively gene expression by binding to the 3 0 UTR region of their target mRNAs (Fabian, Sonenberg, & Filipowicz, 2010) . MiRNAs are implicated in regulating CNS diseases and the development of autoimmune diseases, including MS. Some miRNAs are proposed as potential biomarkers for the diagnosis and prognosis of neurological diseases (Chen, Papp, Szodoray, & Zeher, 2016; Gaudet, Fonken, Watkins, Nelson, & Popovich, 2017; Sheinerman & Umansky, 2013) . MiR-326 was shown to promote Th-17 differentiation and to be positively correlated with IL-17 production in MS patients (Du et al., 2009) . Recently, the expression of various miRNAs has been shown to be significantly altered in the peripheral blood leukocytes, the cerebrospinal fluid and the brain tissue of MS, including miR-145, miR-223, and miR-219 (Bruinsma et al., 2017; Sharaf-Eldin et al., 2017; Sondergaard, Hesse, Krakauer, Sorensen, & Sellebjerg, 2013) . However, the function of miRNAs expressed both in the brain tissue of MS/EAE mice and in activated astrocytes induced by IL-17 remains unknown.
In our previous study, we reported the changes of miRNA expression profiles both in EAE mice and in activated astrocytes with IL-17
stimulation. Meantime, we demonstrated that miR-873 regulated the production of inflammatory cytokines in astrocytes and the development of EAE mice by targeting A20 . Here, we show that miR-409-3p and miR-1896 co-ordinate and regulate inflammatory cytokines production in astrocytes and the pathology of EAE mice through targeting SOCS3. Consequently, specific targeting of astrocytes might prove efficacious for treating MS/EAE and neuroinflammatory diseases.
| MATERIALS AND METHODS

| Animal
C57BL/6 female mice were purchased from the Nanjing University Laboratory Animal Center. All mice were bred under specific pathogen-free conditions. Protocols for animal experiments were approved by the Institutional Animal Use Committee of Chinese Academy of Sciences. were from BD Biosciences (560, 485, 558, 342) . MiRNA mimics and negative control miRNA mimics (NC mimic) were purchased from GenePharma (Shanghai, China) and miRNA sponge were synthetized by GeneChem (Shanghai, China). Anti-GFAP antibody (ab7260 and ab4648)
| Reagents and antibodies
were from Abcam Biotechnology, Inc. Anti-SOCS3 antibody (#2932) was from Cell Signaling Biotechnology, and anti-p-STAT3 (Tyr705, BS4181) and anti-STAT3 (AP0365) antibodies were from Bioworld Technology, Inc. The secondary antibodies of goat anti-mouse IgG and goat antirabbit IgG were purchased from Sigma Biotechnology.
| Induction of EAE and assessment
EAE was induced in female C57BL/6 mice (6-8-week-old) and clinical scores were assessed according to severity from 0 to 5 as described previously .
| Primary astrocyte culture
Primary mouse astrocytes were separated and cultured as described previously . Astrocytes were synchronized by serum starvation for 12 hr before IL-17 stimulation.
| Real-time PCR
Total RNAs from mouse brain tissues and spinal cords as well as cultured astrocytes were extracted with TRIzol reagent (Invitrogen).
Real-time PCR was performed to measure miRNAs and mRNAs as described previously . The primer sequences are shown in Supporting Information Table S1 .
| Western blotting analysis
Total protein was extracted from mouse brain tissues and from primary astrocytes as described previously (Liu et al., 2006) . The expression of protein in samples was normalized by β-actin.
| Plasmid construction and luciferase reporter assay
The SOCS3 3 0 UTR of full-length wild-type (WT), mutant (Mut, mutant binding sites for miR-1896 seed region) or partially deletion mutant (Del, delete binding sites for miR-409-3p seed region) were cloned into the pGL3-Promoter vector (Promega), respectively. The primer sequences for PCR are shown in Supporting Information Table S2 (the mutant of miR-1896 binding sites was completed by overlap PCR). HEK293T cells were transfected with a mixture of 0.5 μg above recombinant pGL3-Promoter vector, 2.5 ng pRL-SV40 and 100 nmol miRNA mimic (miR-409-3p and miR-1896) by using Neon™ electro-transfection system, respectively. The luciferase activity was measured through the dual luciferase reporter gene assay system (Promega) at 48 hr after transfection, and was normalized to Renilla luciferase activity.
| Lentiviral vector generation
Lentiviral vectors carrying with GFP (LV-ctrl) and with targeting astrocyte-specific promoter of glial fibrillary acidic protein (GFAP) (Supporting Information Figure S1 ) were constructed by GeneChem (Shanghai, China). 
| Histopathology
Mice were anesthetized and perfusion-fixed with 4% paraformaldehyde. For immunofluorescent assay (IFA), frozen sections (8 μm) from brain tissues were stained with anti-SOCS3 antibody and anti-GFAP antibody. For evaluating inflammation and demyelination, the paraffin-embedded sections (4 μm) from spinal cords were stained with hematoxylin and eosin (H&E) or luxol fast blue (LFB). Meantime, ultrathin sections of spinal cords were stained with uranyl acetate and lead citrate, and then were observed under electron microscope (EM).
| Statistical analysis
Statistical analysis was performed using GraphPad Prism version 5.0 software with the two-tailed unpaired Student's t test or one-way multiple-range analysis of variance. A Mann-Whitney test was used for nonparametric data (EAE scoring). All results were presented as means AE SE. Values of p < .05 was implied significant.
3 | RESULTS
| Changes of IL-17 secretion, SOCS3 expression and STAT3 phosphorylation in EAE mice
To assess the potential role of IL-17 in inducing SOCS3 expression and phosphorylation of STAT3 in the CNS of EAE mice, we firstly detected the level of IL-17 in serum from EAE mice with different clinical scores, and then investigated the expression of SOCS3 and the level of p-STAT3 in brain tissues. The results showed that IL-17 in serum was gradually increased along with the severity of EAE (Figure 1a) , which was consistent with our previous study . SOCS3 expression was significantly decreased in EAE mice with clinical score 1 (EAE 1) and even lower in EAE mice with clinical score 2 (EAE 2) to EAE 4, compared with negative control ( 
| Identification of miRNAs targeting SOCS3
In a previous study, we reported the changes of miRNA expression profiles both in EAE mice (in vivo) and in activated astrocytes with IL-17 stimulation (in vitro) . We further found that of miRNAs co-upregulated in vivo and in vitro, miR-1896 and miR- Cytokines, particularly chemokines in astrocytes, is required for leukocyte migration into the CNS, which is related to MS/EAE (Guo et al., 2014; Prajeeth et al., 2017; Song et al., 2015) . We investigated whether miR-409-3p and miR-1896 affected CD4 + T cell migration.
Transwell assay revealed that miR-409-3p and miR-1896 mimics significantly promoted CD4 + T cell migration, and co-transfection of miR-409-3p and miR-1896 mimics displayed much more migrative CD4 + T cells (Figure 4g ). 3.6 | MiR-409-3p and miR-1896 play co-operative role in inflammatory cells infiltration into the CNS and demyelination of EAE mice MS is a chronic inflammatory demyelination disease. Evidence suggests that leukocytes cross the blood-brain barrier (BBB) and 
| DISCUSSION
Recent studies have implicated miRNAs as biomarkers of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome (Chen et al., 2016) . Previously, we investigated the changes of miRNA expression profiles both in brain tissues of EAE mice and in activated astrocytes with IL-17 stimulation, and revealed the roles of miR-873 targeting A20 ubiquitin-editing enzyme and of miR-497 targeting hypoxia inducible factor-1α (HIF-1α) in regulating astrocyte function and EAE pathogenesis Shan et al., 2017) . However, few studies reported co-operative effects of miRNAs on regulating inflammatory autoimmune disease. In this study, we aimed to uncover the role of co-operative activity of miRNAs in regulating astrocytes functions and EAE pathogenesis. Here, we illustrated miR-409-3p and miR-1896 effects on the production of inflammatory cytokines in activated astrocytes with IL-17 treatment and EAE development (Figure 7) . Overexpression of miR-1896 or miR-409-3p decreased SOCS3 expression and promoted p-STAT3 level, resulting in the promoted production of inflammatory cytokines Many studies suggest a clear association of Th17 with disease severity and progression in MS/EAE (Waisman et al., 2015) . IL-17RA is the major target of IL-17 signaling and is upregulated in microglia and particularly in astrocytes in EAE (Gaffen, 2011; Kang et al., 2010) .
In addition, IL-17 interacts with its receptor on endothelial cells and astrocytes, which contributes to BBB breakdown and T cell infiltration into the CNS in MS/EAE (Kebir et al., 2007; Waisman et al., 2015) .
The production of inflammatory cytokines is substantially increased in astrocytes treated with IL-17. However, the mechanism of IL-17 in regulating inflammatory cytokines productions in astrocytes and EAE pathogenesis remains unclear.
In CNS, SOCS3 expression in astrocytes is induced by IL-4, IL-6, IL-10, Interferon-β (IFN-β), and lipopolysaccharide (LPS), which partly through JAK/STAT3 pathway (Baker, Akhtar, & Benveniste, 2009 ). Furthermore, STAT3 can directly bind to the IL-17 promoters and promotes IL-17 production (Tamiya, Kashiwagi, Takahashi, Yasukawa, & Yoshimura, 2011) . IL-17 in turn triggers positivefeedback loop of IL-6 signaling (Ogura et al., 2008) . However, SOCS3 is a negative modulator of JAK/STAT3 pathway and a feedback inhibitor of activated cytokine receptor signaling (Noh et al., 2017) . Here, we demonstrated that the expression of SOCS3 was significantly decreased in astrocytes treated with IL-17 for 6 hr, whereas the level of p-STAT3 and the production of inflammatory cytokines and chemokines displayed a significant upregulation, indicating lower expression of SOCS3 promoting the productions of inflammatory cytokines through upregulating p-STAT3 in astrocytes.
We also found that the SOCS3 expression was reduced and the STAT3 phosphorylation was gradually upregulated following the development of EAE. It was shown that modulating SOCS3 expression and STAT3 activation would be a target for drug development aimed at controlling inflammation and several types of autoimmune diseases (Cianciulli et al., 2017; Park et al., 2014) .
MiRNAs play critical roles in the development and regulation of the immune system and autoimmune diseases, including MS (Noh et al., 2017) . It has been shown that miR-146a modulates autoreactive Th17 cell differentiation and miR-146a-deficient mice develop more severe EAE . In PBMCs of relapsing remitting MS patients, miRNA expression profile analysis indicates that some miRNAs are overexpressed, such as miR-146a, miR-146b, and miR-155 (Devier, Lovera, & Lukiw, 2015) . MiR-219 in the cerebrospinal fluid (CSF) may be a potential biomarker for MS diagnosis (Bruinsma et al., 2017 ). An important feature of miRNA is that several miRNAs can target the same gene, regulating the same or related physiological functions (Ambros, 2004; Bartel, 2004) . Here, we illustrated that SOCS3 was a functional target of miR-409-3p and miR-1896. Overexpression of miR-1896 or miR-409-3p in astrocytes significantly reduced SOCS3 expression, enhanced p-STAT3 level and inflammatory cytokine production. Importantly, miR-409-3p and miR-1896 mimics resulted in a co-operative effect on them. It is similar to vitro, miR-409-3p sponge and LV-miR-1896 sponge effectively decreased inflammatory cytokines production and ameliorated the development of EAE through inhibiting the SOCS3 expression.
Inflammation of the CNS is a common feature of neurological disorders and injuries, and is characterized by activation of glial cells and invasion of peripheral immune cells into the CNS (Osso & Chan, 2015) . Here, our results indicated that overexpression of miR-409-3p or miR-1896 in EAE mice developed severe inflammatory cell infiltration in CNS, whereas inhibiting endogenous miR-1896 or miR-409-3p reduced inflammation cell infiltration. Notably, miR-409-3p and miR-1896 co-operatively exacerbated inflammatory cell infiltration, but miR-1896 sponge and LV-miR-409-3p sponge cooperatively lighten inflammation in spinal cords of EAE mice. In addition, inhibition of endogenous miR-409-3p and miR-1896 simultaneously resulted in lighter demyelination in EAE mice. Therefore, the co-upregulation of miR-409-3p and miR-1896 in EAE mice greatly represses SOCS3 expression and enhances the phosphorylation of STAT3, which in turn contributes to the production of a large number of inflammatory cytokines and CNS damage, thus exacerbating the EAE process.
| CONCLUSION
Taken together, our data demonstrate that the co-upregulation of miR-409-3p and miR-1896 both in EAE mice and in activated astrocytes by IL-17 stimulation, co-operatively regulates the production of inflammatory cytokines and chemokines in astrocytes and in EAE mice via regulating the SOCS3/STAT3 pathway, which is responsible for EAE development. Thus, these findings on the underlying mechanisms that regulate astrocyte function and the EAE pathophysiological process open new means in understanding of MS pathophysiology and potentially relevant therapeutic strategies. 
